Gut microbiota-derived SCFAs and MetS-related nephropathy
Metabolic syndrome (MetS) is a group of complex disorders characterized by abnormalities in the metabolism of proteins, fats, carbohydrates, and other substances in the human body. The kidney plays a vital role in these metabolic processes. Similarly, metabolic disorders can lead to renal damage, wh...
Saved in:
| Main Authors: | Xiaofang Tian, Li Sun, Shengjie Guo, Liying Yuan, Tang Zhang, Chengqian Huang, Tingting He, Qianfeng Jiang, Yizhou Zeng |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Nutrition |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fnut.2025.1561271/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Microbiota-derived metabolites as drivers of gut–brain communication
by: Hany Ahmed, et al.
Published: (2022-12-01) -
The emerging role of microbiota derived SCFAs in neurodegenerative disorders
by: Samuel Wachamo, et al.
Published: (2025-07-01) -
The Impact of Short Chain Fatty Acids Derived from Gut Microbiota on Human Immune Function ——Analysis based on Bibliometrics
by: MIN Yu-ze, et al.
Published: (2025-07-01) -
Targeting gut microbiota for diabetic nephropathy treatment: probiotics, dietary interventions, and fecal microbiota transplantation
by: Xiaoran Wang, et al.
Published: (2025-06-01) -
Modulating gut microbiota with SCFAs and high-fiber diets to mitigate PM2.5-induced hypertension in mice
by: Kaixin Yan, et al.
Published: (2025-09-01)